Xenon Pharmaceuticals Inc. (NASDAQ:XENE) ranks among the 30 stocks expected to beat the market by 20 percentage points this ...

In a June 24, 2025, podcast, Goldman Sachs’ Christian Mueller-Glissmann and Alexandra Wilson-Elizondo examined the dynamics ...

RBC Capital maintained its Outperform rating on Xenon Pharmaceuticals Inc. (NASDAQ:XENE) and increased its price target from $55 to $57 on June 13.

In this article, we identify the top 10 most impactful articles for pediatric hospital medicine in 2025, as presented at the ...

Akebia Therapeutics, Inc. (NASDAQ:AKBA) is one of the 13 Stocks Under $5 With High Upside Potential. On May 29, Leerink ...

In the assessment of 12-month price targets, analysts unveil insights for Axsome Therapeutics, presenting an average target of $179.18, a high estimate of $200.00, and a low estimate of $150.00.

Health P.E.I. says reduced staffing will mean oncology patients usually treated at Prince County Hospital will now have to ...

Autism spectrum disorders are a group of neurodevelopmental disorders that are characterized by impaired social interaction and communication skills, and are often accompanied by other behavioural ...